(688837)"EVOPOINT BIOSCIENCES CO., LTD."Announcement on Change of Securities Affairs Representative
Filed with SSE · Stock code 688837 · · 3 pages · Chinese
Summary by 6ix AI
The previous representative, Liu Luting, resigned due to work adjustments but will continue in another role within the company.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Evopoint Biosciences Co Ltd on 6ix
Earlier from Evopoint Biosciences
- (688837)"EVOPOINT BIOSCIENCES CO., LTD."Announcement on Opening of Dedicated Settlement Accounts for Cash Management Products Purchased with Raised Funds
- (688837)"EVOPOINT BIOSCIENCES CO., LTD."Announcement on Approval by the National Medical Products Administration of the Clinical Trial Application for XNW26018 Tablets
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Resolutions of the 17th Meeting of the 2nd Board of Directors
Follow Evopoint Biosciences into a list and get an email when it puts out news.
Follow Evopoint Biosciences